Table 2: composition of cohorts and validated measures used.

From: Predicting and understanding non-adherence in chronic disease: cross-cohort validation and structural equation modeling of the SPUR 6/24 tool

 

7,8

USA, DT2

7,8

France, DT2

4

UK, DT2

5,6

UK, COPD

Dolgin, Lee

2025 (pending)

USA, Cardiovascular

Pathology

Type 2 diabetes

Type 2 diabetes

Type 2 diabetes

COPD

Hypertension

Number of patients

501

245

378

200

571

NAR6 (SPUR)

x

x

x

x

x

NAR24 (SPUR)

x

x

x

x

x

HbA1c

 

x

x

  

MPR

  

x

x

 

MMAS-8

x

   

x

MARS

 

x

x

  

BMQ-specific

x

x

x

 

x